Abbott | La Marge Brute Sur Les Ventes



Gross Profit On Sales Changement Date
Abbott USD 5.92B 114M 2025-03
Agilent USD 899M 18M 2025-01
AtriCure USD 92.63M 9K 2025-03
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.24B 290M 2024-12
Bio-Rad Laboratories USD 355.1M 803K 2024-12
Boston Scientific USD 3.2B 97M 2025-03
Cooper Companies USD 660.2M 17.5M 2025-01
Danaher USD 3.53B 364M 2025-03
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Globus Medical USD 393.86M 38.67M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.02M 963K 2025-03
Pfizer USD 11.12B 987M 2025-03
Smith & Nephew USD 2.07B 98M 2024-12
Solventum Corp 1.12B 46M 2024-12
Stryker USD 4.2B 681M 2024-12
Tandem Diabetes Care USD 118.41M 39.05M 2025-03
Teleflex USD 389.44M 50.48M 2025-03
Terumo JPY 145.12B 5.66B 2024-12
Thermo Fisher Scientific USD 4.31B 514M 2025-03
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Abbott La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.